Literature DB >> 1913597

Chromosome analysis of 96 uterine leiomyomas.

N Pandis1, S Heim, G Bardi, U M Flodérus, H Willén, N Mandahl, F Mitelman.   

Abstract

From September 1989 to May 1990, we attempted cytogenetic analysis on 96 uterine leiomyomas removed from 64 women. Of the 90 tumors in which analysis was successful, 59 had a normal karyotype while 31 had clonal abnormalities. The most common aberration (13 tumors) was 7q-, mostly del(7)(q21.2q31.2); in two tumors with +12 and t(12;14) as the primary abnormalities, the 7q- was obviously a secondary change since it was found only in a subclone. A t(12;14)(q14-15;q23-24) was detected in two tumors, complex aberrations involving both 12q14-15 and 14q23-24 were also present in two, and rearrangements of 12q without concomitant 14q changes were seen in another two myomas. Rearrangements of 6p were present in five tumors, and trisomy 12 was found in two. More than one abnormality could be detected in 17 leiomyomas. Evidence of clonal evolution in the form of subclones was found in eight tumors, all of which were cellular and had histologically detectable mitotic activity. In addition to their clonal complexity, these myomas also frequently exhibited clonal telomeric associations (four tumors) and ring chromosome formation (three tumors; twice affecting chromosome 1). Monosomy 22 occurred as a secondary abnormality in three tumors; it, too, may reflect a preferred pathway in the karyotypic evolution of uterine leiomyomas.

Entities:  

Mesh:

Year:  1991        PMID: 1913597     DOI: 10.1016/0165-4608(91)90229-n

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  23 in total

1.  Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.

Authors:  Jae-Ho Lee; Tae-Yung Ryu; Chi-Heum Cho; Dae-Kwang Kim
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

Review 2.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

3.  Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays.

Authors:  Wayne Bowden; Josh Skorupski; Ertug Kovanci; Aleksandar Rajkovic
Journal:  Mol Hum Reprod       Date:  2009-06-30       Impact factor: 4.025

4.  Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation.

Authors:  B J Quade; C M McLachlin; V Soto-Wright; J Zuckerman; G L Mutter; C C Morton
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Fusion of the HMGA2 and NFIB genes in lipoma.

Authors:  M Nilsson; I Panagopoulos; F Mertens; N Mandahl
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

6.  Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.

Authors:  C D Fletcher; P Dal Cin; I de Wever; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van den Berghe; R Vanni; H Willén
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

7.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 8.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.

Authors:  C Sreekantaiah; M Ladanyi; E Rodriguez; R S Chaganti
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

9.  Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas.

Authors:  C Orndal; N Mandahl; A Rydholm; H Willén; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Tenascin-X and leukemia inhibitory factor receptor are down-regulated in leiomyoma compared with normal myometrium.

Authors:  Sun Ok Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.